Jack Nathan Medical Corp Cash Flow Conversion Efficiency
Jack Nathan Medical Corp cash flow conversion efficiency. Based on the latest financial reports, Jack Nathan Medical Corp (JNH) has a cash flow conversion efficiency ratio of 0.214x as of October 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-1.04 Million ≈ $-750.77K USD) by net assets (CA$-4.85 Million ≈ $-3.51 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Jack Nathan Medical Corp (2019–2023)
Cash flow conversion efficiency of Jack Nathan Medical Corp from 2019 to 2023. This chart illustrates how Jack Nathan Medical Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. View JNH share price today for real-time trading data and today's change.
Jack Nathan Medical Corp Cash Flow Conversion Ratio Explained
Jack Nathan Medical Corp cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Jack Nathan Medical Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jack Nathan Medical Corp ranked by their cash flow conversion efficiency. Also see Jack Nathan Medical Corp (JNH) market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Nuvve Holding Corp
NASDAQ:NVVEW
|
2.691x |
|
Innoviz Technologies Ltd
NASDAQ:INVZW
|
-0.153x |
|
RPCG PCL F
F:R4Q
|
0.061x |
|
Ordinary Fully Paid Deferred Settlement
AU:CNJDG
|
-0.239x |
|
Seelos Therapeutics, Inc.
NASDAQ:SEELQ
|
0.035x |
|
Godha Cabcon & Insulation Limited
NSE:GODHA
|
-1.064x |
|
Solartron Public Company Limited
F:TUUF
|
0.037x |
|
Advantage Solutions Inc
NASDAQ:ADVWW
|
0.090x |
Annual Cash Flow Conversion Efficiency for Jack Nathan Medical Corp (2019–2023)
The table below shows the annual cash flow conversion efficiency of Jack Nathan Medical Corp from 2019 to 2023. Review JNH FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-01-31 | CA$-1.87 Million ≈ $-1.35 Million |
CA$-2.00 Million ≈ $-1.45 Million |
1.073x | +200.96% |
| 2022-01-31 | CA$4.08 Million ≈ $2.95 Million |
CA$-4.34 Million ≈ $-3.14 Million |
-1.063x | -1019.79% |
| 2021-01-31 | CA$8.52 Million ≈ $6.16 Million |
CA$-809.16K ≈ $-585.33K |
-0.095x | +90.15% |
| 2020-01-31 | CA$389.59K ≈ $281.83K |
CA$-375.55K ≈ $-271.66K |
-0.964x | -115.13% |
| 2019-01-31 | CA$76.20K ≈ $55.12K |
CA$485.65K ≈ $351.31K |
6.373x | -- |
About Jack Nathan Medical Corp
Jack Nathan Medical Corp., together with its subsidiaries, designs, builds, and operates medical clinics in Canada and Mexico. It operates Jack Nathan MedSpa, a aesthetic wellness platform that provides aesthetic and wellness services, including injectables, skin rejuvenation, laser treatments and therapies, skin care therapies, and wellness treatments. In addition, the company's platform also su… Read more